Traditional diagnosis of hemoglobinopathies rely on separation and accurate quantification of hemoglobin (Hb) fractions using alkaline and acid electrophoresis, isoelectric focusing (IEF) and/or High Performance Liquid Chromatography (HPLC). Recent reports have suggested capillary electrophoresis (CE) as an alternate method for screening. We evaluated a new CE system the Sebia CapillaryS 2 (Evry Cedex, France) and compared it to IEF and HPLC. For this evaluation samples referred to our laboratory for routine hemoglobinopathy screening or as cord bloods sent for confirmation of a variant detected as a result of newborn screening were analyzed using all three techniques. IEF was performed with the Resolve IEF kit (Perkin Elmer,Wallac Oy, Finland). HPLC was done on the BioRad Variant II (Munich, Germany) using the Hb A2/Hb A1c Dual program. The CE was performed using the “Capillarys Hemoglobin(E) kit”. Suspected rare variants were further investigated with DNA investigations, including PCR and direct nucleotide sequencing. Variant hemoglobins were detected in 156 of 764 samples (Table 1). The correlation between IEF, HPLC and CE was excellent. One variant (Hb Toulon) was not detected by the CE but ran with Hb F. The CE system did not report the Hb F value on samples with very low (< 1.0%) Hb F by HPLC. Two cases of Hb Constant Spring were identified by CE but not by either IEF or HPLC. The correlation of both Hb F and Hb A2 reported between the CE and HPLC systems were excellent (R > 0.99 and 0.98, Figure 1 and Figure 2 respectively). The positive bias of Hb A2 seen in HPLC when Hb S is present was lower in the CE. However, the CE system demonstrated a negative bias for Hb A2 if Hb C was present. CE was the only system capable of separating Hb A2 from Hb E. We conclude that CE is comparable to both IEF and HPLC for separation and quantification of hemoglobin fractions; this system has the added advantage of reporting Hb A2 in the presence of Hb E and consistently identifies Hb Constant Spring, which is not easily detected on IEF or HPLC. Further this CE system is user friendly and holds promise as a tool for newborn screening and routine laboratory hemoglobinopathy investigations.

Hemoglobinopathy Detected

HemoglobinopathyNumber
β Thalassemia 99 
Hb S trait 55 
Cord with Hb Barts 28 
Hb C trait 13 
Hb E trait 12 
Hb D trait 
α variant (not yet identified) 
Hb Barts + Hb S trait 
Hb Barts + Hb D trait 
Hb S disease 
Hb Barts + Hb E trait 
Hb E +β Thalassemia 
Hb H disease 
Hb Constant Spring 
Hb J Baltimore 
Hb Toulon 
δ variant (not identified) 
Hb S + Hb C 
Hb Barts + Hb C trait 
Hb Q Thailand + --SEA/αα 
Homozygous Hb E + Hb Constant Spring 
Hb S + Hb Kenya 
Hb J Roviga 
Hb Beograd 
Hb G Coushatta 
Hb Sirian 
Hb Titusville 
B variant (not identified yet) 
Total Abnormal 255 
No hemoglobinopathy detected 509 
Total 764 
HemoglobinopathyNumber
β Thalassemia 99 
Hb S trait 55 
Cord with Hb Barts 28 
Hb C trait 13 
Hb E trait 12 
Hb D trait 
α variant (not yet identified) 
Hb Barts + Hb S trait 
Hb Barts + Hb D trait 
Hb S disease 
Hb Barts + Hb E trait 
Hb E +β Thalassemia 
Hb H disease 
Hb Constant Spring 
Hb J Baltimore 
Hb Toulon 
δ variant (not identified) 
Hb S + Hb C 
Hb Barts + Hb C trait 
Hb Q Thailand + --SEA/αα 
Homozygous Hb E + Hb Constant Spring 
Hb S + Hb Kenya 
Hb J Roviga 
Hb Beograd 
Hb G Coushatta 
Hb Sirian 
Hb Titusville 
B variant (not identified yet) 
Total Abnormal 255 
No hemoglobinopathy detected 509 
Total 764 

Hb F: HPLC vs CE

Hb A2: HPLC vs CE

Disclosure: No relevant conflicts of interest to declare.

Author notes

*

Corresponding author

Sign in via your Institution